| Stage | CGNX | % of rev | DHR | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $313M | 100.00% | $6.6B | 100.00% | DHR ×20.91 |
| Gross profit | $222M | 70.76% | $3.8B | 58.54% | CGNX +12.2pp |
| Operating income | $101M | 32.17% | $1.2B | 19.00% | CGNX +13.2pp |
| Pre-tax income | $103M | 32.96% | $1.1B | 17.27% | CGNX +15.7pp |
| Net income | $85M | 27.07% | $1.2B | 18.84% | CGNX +8.2pp |
| Stage | CGNX | DHR | Gap · A − B |
|---|---|---|---|
| Revenue | $313M100.00% | $6.6B100.00% | DHR ×20.91 |
| Gross profit | 70.76%$222M | 58.54%$3.8B | CGNX +12.2pp |
| Operating income | 32.17%$101M | 19.00%$1.2B | CGNX +13.2pp |
| Pre-tax income | 32.96%$103M | 17.27%$1.1B | CGNX +15.7pp |
| Net income |
| 27.07%$85M |
| 18.84%$1.2B |
| CGNX +8.2pp |
No disclosed counterparties: DHR.
None